Literature DB >> 31243299

Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-κB-CCL2 signaling in lung cancer.

Lisha Zhou1, Yanyu Jiang2, Xiaojun Liu2, Lihui Li1, Xuguang Yang1, Changsheng Dong1, Xiaoli Liu2, Yuli Lin3, Yan Li4, Jinha Yu5, Rui He3, Shenglin Huang2, Guangwei Liu4, Yanmei Zhang6, Lak Shin Jeong5, Robert M Hoffman7, Lijun Jia8.   

Abstract

Tumor-associated macrophages (TAMs) are the most abundant cancer stromal cells and play an essential role in tumor immunosuppression, providing a suitable microenvironment for cancer development and progression. However, mechanisms of regulating TAMs infiltration in tumor sites are not fully understood. Here, we show that inactivation of neddylation pathway significantly inhibits infiltration of TAMs, leading to the suppression of lung cancer metastasis. RNA-sequencing analysis revealed that neddylation inactivation suppresses the transactivation of chemotactic cytokine ligand 2 (CCL2). Mechanistically, neddylation inactivation inhibits the activity of Cullin-RING ligases (CRLs) and induces the accumulation of its substrate IκBα to block NF-κB transcriptional activity and CCL2 transactivation. As a result, neddylation inactivation exhibits lower chemotaxis of monocytes, thereby decreasing TAMs infiltration, which can be alleviated by CCL2 addition. Moreover, the expression level of NEDD8 is positively correlated with high CCL2 expression in lung adenocarcinoma, conferring a worse overall patient survival. Together, neddylation pathway promotes CCL2 transactivation and TAMs infiltration in lung cancer to provide a tumor-promoting microenvironment, which validates neddylation pathway as a promising target for anti-TAMs therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31243299     DOI: 10.1038/s41388-019-0840-4

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  2 in total

1.  Overactivated neddylation pathway as a therapeutic target in lung cancer.

Authors:  Lihui Li; Mingsong Wang; Guangyang Yu; Ping Chen; Hui Li; Dongping Wei; Ji Zhu; Li Xie; Huixun Jia; Jieyi Shi; Chunjie Li; Wantong Yao; Yanchun Wang; Qiang Gao; Lak Shin Jeong; Hyuk Woo Lee; Jinha Yu; Fengqing Hu; Ju Mei; Ping Wang; Yiwei Chu; Hui Qi; Meng Yang; Ziming Dong; Yi Sun; Robert M Hoffman; Lijun Jia
Journal:  J Natl Cancer Inst       Date:  2014-05-22       Impact factor: 13.506

2.  Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target.

Authors:  Qiang Gao; Guang-Yang Yu; Jie-Yi Shi; Li-Hui Li; Wen-Juan Zhang; Zhi-Chao Wang; Liu-Xiao Yang; Meng Duan; Hu Zhao; Xiao-Ying Wang; Jian Zhou; Shuang-Jian Qiu; Lak Shin Jeong; Li-Jun Jia; Jia Fan
Journal:  Oncotarget       Date:  2014-09-15
  2 in total
  19 in total

1.  A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy.

Authors:  Iqra Bano; Moolchand Malhi; Min Zhao; Liviu Giurgiulescu; Hira Sajjad; Marek Kieliszek
Journal:  3 Biotech       Date:  2022-03-29       Impact factor: 2.406

2.  NEDD8-conjugating enzyme E2 UBE2F confers radiation resistance by protecting lung cancer cells from apoptosis.

Authors:  Lisha Zhou; Changsheng Dong; Zhuoming Xu; Xinran Wang; Luyi Zhang; Siyuan Chen; Jiahao Chen; Yingying Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2021-11-15       Impact factor: 3.066

Review 3.  Association Between Neddylation and Immune Response.

Authors:  Jiali Zhu; Feng Chu; Meirong Zhang; Wenhuan Sun; Fangfang Zhou
Journal:  Front Cell Dev Biol       Date:  2022-05-05

4.  Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia.

Authors:  Zhao Xu; Yifeng Sun; Zheng Wei; Jifeng Jiang; Jiadai Xu; Peng Liu
Journal:  Onco Targets Ther       Date:  2020-07-16       Impact factor: 4.147

5.  Pulmonary Inflammation and KRAS Mutation in Lung Cancer.

Authors:  Phouthone Keohavong; Y Peter Di
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer.

Authors:  Man Zhang; Wei Yang; Peng Wang; Yu Deng; Yu-Ting Dong; Fang-Fang Liu; Rui Huang; Peng Zhang; Ya-Qi Duan; Xin-Dong Liu; Dandan Lin; Qian Chu; Bo Zhong
Journal:  Nat Commun       Date:  2020-11-30       Impact factor: 14.919

7.  Induction of NEDD8-conjugating enzyme E2 UBE2F by platinum protects lung cancer cells from apoptosis and confers to platinum-insensitivity.

Authors:  Lisha Zhou; Jin Zhu; Wangyang Chen; Yanyu Jiang; Tao Hu; Yinxia Wang; Xiaoling Ye; Mengxi Zhan; Chenghao Ji; Zhuoming Xu; Xinran Wang; Yuanlong Gu; Lijun Jia
Journal:  Cell Death Dis       Date:  2020-11-12       Impact factor: 8.469

Review 8.  Research trends in pharmacological modulation of tumor-associated macrophages.

Authors:  Neng Wang; Shengqi Wang; Xuan Wang; Yifeng Zheng; Bowen Yang; Juping Zhang; Bo Pan; Jianli Gao; Zhiyu Wang
Journal:  Clin Transl Med       Date:  2021-01

9.  Effect of apigenin on whole transcriptome profile of TNFα-activated MDA-MB-468 triple negative breast cancer cells.

Authors:  David Bauer; Elizabeth Mazzio; Aaron Hilliard; Ebenezer T Oriaku; Karam F A Soliman
Journal:  Oncol Lett       Date:  2020-01-22       Impact factor: 2.967

10.  CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer.

Authors:  Zhenxing Wang; Yan Zhao; Hongyan Xu; Feihai Liang; Qingxu Zou; Chen Wang; Jingyuan Jiang; Fengwu Lin
Journal:  J Cell Mol Med       Date:  2020-09-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.